Patents by Inventor Tapasree Banerji

Tapasree Banerji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Amide compounds, pharmaceutical compositions thereof, and methods of using the same
    Patent number: 11325886
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: May 10, 2022
    Assignee: Oregon Health & Science University
    Inventors: Thomas S. Scanlan, James Matthew Meinig, Skylar J. Ferrara, Tapasree Banerji, Tania Banerji
  • AMIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
    Publication number: 20210284599
    Abstract: Amide compounds are disclosed. Also disclosed are pharmaceutical compositions comprising the compounds as well as methods of treating neurodegenerative diseases that involve administering the compounds or pharmaceutical compositions to a subject.
    Type: Application
    Filed: August 14, 2017
    Publication date: September 16, 2021
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. SCANLAN, James Matthew MEINIG, Skylar J. FERRARA, Tapasree BANERJI, Tania BANERJI
  • Derivatives of sobetirome
    Patent number: 11104654
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: August 31, 2021
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig
  • Derivatives of sobetirome
    Patent number: 10870616
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: December 22, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji
  • DERIVATIVES OF SOBETIROME
    Publication number: 20200325092
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Application
    Filed: December 9, 2019
    Publication date: October 15, 2020
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas SCANLAN, Jordan DEVEREAUX, Andrew PLACZEK, Tapasree BANERJI, Skylar FERRARA, James Matthew MEINIG, Tania BANERJI
  • DERIVATIVES OF SOBETIROME
    Publication number: 20200181103
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Application
    Filed: July 12, 2019
    Publication date: June 11, 2020
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig
  • Derivatives of sobetirome
    Patent number: 10544075
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Grant
    Filed: May 18, 2017
    Date of Patent: January 28, 2020
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas Scanlan, Jordan Devereaux, Andrew Placzek, Tapasree Banerji, Skylar Ferrara, James Matthew Meinig, Tania Banerji
  • Derivatives of sobetirome
    Patent number: 10392356
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: August 27, 2019
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig
  • DERIVATIVES OF SOBETIROME
    Publication number: 20190210950
    Abstract: Disclosed are halo substituted derivative compounds of sobetirome with improved pharmacological characteristics relative to sobetirome, pharmaceutical compositions that include those compounds and methods of treating diseases such as neurodegenerative disorders using those pharmaceutical compositions.
    Type: Application
    Filed: May 18, 2017
    Publication date: July 11, 2019
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas SCANLAN, Jordan DEVERAUX, Andrew PLACZEK, Tapasree BANERJI, Skylar FERRARA, James Matthew MEINIG, Tania BANERJI
  • DERIVATIVES OF SOBETIROME
    Publication number: 20180057472
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Application
    Filed: June 6, 2017
    Publication date: March 1, 2018
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig
  • Derivatives of sobetirome
    Patent number: 9701650
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: July 11, 2017
    Assignee: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig
  • DERIVATIVES OF SOBETIROME
    Publication number: 20160244418
    Abstract: Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
    Type: Application
    Filed: February 19, 2016
    Publication date: August 25, 2016
    Applicant: OREGON HEALTH & SCIENCE UNIVERSITY
    Inventors: Thomas S. Scanlan, Andrew Placzek, Tapasree Banerji, Sky Ferrara, James Matthew Meinig